Vector Group Reports First Quarter 2022 Financial Results
Continued Strong Revenue Growth in Tobacco Segment, with First Quarter Tobacco Segment Revenues Increased by 15% from Prior Year Period
First Quarter 2022 Highlights:
-
Consolidated revenues of
$312.0 million , increased by 15.1% or$41.1 million compared to the prior year period-
Tobacco Segment revenues of
$309.0 million , increased by 15.1% compared to the prior year period. - Tobacco Segment unit volume increase of 18.7% compared to the prior year period.
- Liggett’s wholesale and retail market share increases to 5.2% from 3.9% and 4.2%, respectively, in the prior year period.
-
Tobacco Segment revenues of
-
Reported net income attributed to
Vector Group of$32.5 million or$0.21 per diluted common share, compared to$32.0 million or$0.20 per diluted common share in the prior year period; Adjusted Net Income from Continuing Operations of$26.6 million or$0.17 per diluted common share, compared to$34.9 million or$0.22 per diluted common share in the prior year period -
Reported operating income of
$75.1 million , declined by$0.8 million compared to the prior year period-
Tobacco Segment operating income of
$77.6 million , declined by 4.9% or$4.0 million compared to the prior year period, attributable to the investment in Montego’s significant volume and market share growth.
-
Tobacco Segment operating income of
-
Adjusted EBITDA from Continuing Operations of
$77.1 million , declined by 1.2% or$0.9 million compared to the prior year period-
Tobacco Segment Adjusted EBITDA from Continuing Operations of
$77.1 million , declined by 4.4% or$3.6 million compared to the prior year period, attributable to the investment in Montego’s significant volume and market share growth.
-
Tobacco Segment Adjusted EBITDA from Continuing Operations of
-
Strong liquidity with cash and cash equivalents of
$238 million and investment securities and long-term investments of$183 million atMarch 31, 2022 -
Cash dividends of
$32 million returned to stockholders at a rate of$0.20 per common share
“Vector Group delivered strong tobacco business revenue performance in the first quarter as we capitalized on favorable market opportunities to substantially increase value and market share,” said
GAAP Financial Results
First quarter 2022 revenues were
Non-GAAP Financial Measures
Non-GAAP financial results include adjustments for litigation settlements and judgment expense, impact of Master Settlement Agreement settlements, transaction expenses, acceleration of stock compensation expense (for purposes of Adjusted Net Income from Continuing Operations and Adjusted Operating Income only), net gains on sales of assets (for purposes of Adjusted EBITDA from Continuing Operations and Adjusted Operating Income only), and loss on extinguishment of debt (for purposes of Adjusted EBITDA from Continuing Operations and Adjusted Net Income from Continuing Operations). For purposes of Adjusted EBITDA from Continuing Operations only, adjustments include equity in earnings from investments, equity in (earnings) losses from real estate ventures, stock-based compensation expense, litigation settlements and judgment expense, impact of Master Settlement Agreement settlements, transaction expenses, and other, net. For purposes of Adjusted Net Income from Continuing Operations only, adjustments include net interest expense capitalized to real estate ventures and adjustments for a derivative associated with a guarantee. Reconciliations of non-GAAP financial measures to the comparable GAAP financial results for the last twelve months ended
Three months ended
Adjusted EBITDA from Continuing Operations attributed to Vector (as described in Table 2 attached hereto) were
Adjusted Net Income from Continuing Operations (as described in Table 3 attached hereto) was
Adjusted Operating Income (as described in Table 4 attached hereto) was
Consolidated Balance Sheet
Vector maintained significant liquidity at
Vector continued its longstanding practice of paying a quarterly cash dividend in the first quarter of 2022. Vector returned
Tobacco Segment Financial Results
For the first quarter of 2022, the Tobacco segment had revenues of
Operating Income from the Tobacco segment was
Non-GAAP Financial Measures
Tobacco Adjusted Operating Income (as described in Table 5 attached hereto) for the first quarter of 2022 was
For the three months ended
According to data from
According to data from
Non-GAAP Financial Measures
Adjusted EBITDA from Continuing Operations, Adjusted Net Income from Continuing Operations, Adjusted Operating Income, Tobacco Adjusted Operating Income, Tobacco Adjusted EBITDA, (“the Non-GAAP Financial Measures”) are financial measures not prepared in accordance with GAAP. The Company believes that the Non-GAAP Financial Measures are important measures that supplement discussions and analysis of its results of operations and enhances an understanding of its operating performance. The Company believes the Non-GAAP Financial Measures provide investors and analysts with a useful measure of operating results unaffected by differences in capital structures and ages of related assets among otherwise comparable companies.
Management uses the Non-GAAP Financial Measures as measures to review and assess operating performance of the Company’s business, and management and investors should review both the overall performance (GAAP net income) and the operating performance (the Non-GAAP Financial Measures) of the Company’s business. While management considers the Non-GAAP Financial Measures to be important, they should be considered in addition to, but not as substitutes for or superior to, other measures of financial performance prepared in accordance with GAAP, such as operating income, net income and cash flows from operations. In addition, the Non-GAAP Financial Measures are susceptible to varying calculations and the Company’s measurement of the Non-GAAP Financial Measures may not be comparable to those of other companies. Attached hereto as Tables 2 through 6 is information relating to the Company’s Non-GAAP Financial Measures for the last twelve months ended
Conference Call to Discuss First Quarter 2022 Results
As previously announced, Vector will host a conference call and webcast on
A replay of the call will be available shortly after the call ends on
About
Investors and others should note that we may post information about the Company or its subsidiaries on our website at www.VectorGroupLtd.com and/or at the websites of those subsidiaries or, if applicable, on their accounts on LinkedIn,
Forward-Looking and Cautionary Statements
This press release includes forward-looking statements within the meaning of the federal securities law. All statements other than statements of historical or current facts made in this document are forward-looking. We identify forward-looking statements in this document by using words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may be,” “continue’” “could,” “potential,” “objective,” “plan,” “seek,” “predict,” “project” and “will be” and similar words or phrases or their negatives. Forward-looking statements reflect our current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons.
Risks and uncertainties that could cause our actual results to differ significantly from our current expectations are described in our 2021 Annual Report on Form 10-K and in our Quarterly Report on Form 10-Q for the quarter ended
[Financial Tables Follow]
TABLE 1
CONSOLIDATED STATEMENTS OF OPERATIONS (Dollars in Thousands, Except Per Share Amounts) |
|||||
On |
|||||
|
Three Months Ended |
||||
|
|
||||
|
2022 |
|
2021 |
||
|
(Unaudited) |
||||
Revenues: |
|
|
|
||
Tobacco* |
$ |
309,048 |
|
$ |
268,463 |
Real estate |
|
2,994 |
|
|
2,525 |
Total revenues |
|
312,042 |
|
|
270,988 |
|
|
|
|
||
Expenses: |
|
|
|
||
Cost of sales: |
|
|
|
||
Tobacco* |
|
211,537 |
|
|
164,031 |
Real estate |
|
1,278 |
|
|
876 |
Total cost of sales |
|
212,815 |
|
|
164,907 |
|
|
|
|
||
Operating, selling, administrative and general expenses |
|
24,029 |
|
|
30,101 |
Litigation settlement and judgment expense |
|
72 |
|
|
5 |
Operating income |
|
75,126 |
|
|
75,975 |
|
|
|
|
||
Other income (expenses): |
|
|
|
||
Interest expense |
|
(25,098) |
|
|
(28,721) |
Loss on extinguishment of debt |
|
— |
|
|
(21,362) |
Equity in (losses) earnings from investments |
|
(2,242) |
|
|
577 |
Equity in (losses) earnings from real estate ventures |
|
(1,877) |
|
|
1,589 |
Other, net |
|
(1,145) |
|
|
2,706 |
Income before provision for income taxes |
|
44,764 |
|
|
30,764 |
Income tax expense |
|
12,222 |
|
|
9,214 |
Income from continuing operations |
|
32,542 |
|
|
21,550 |
Income from discontinued operations, net of income taxes |
|
— |
|
|
10,407 |
Net income |
$ |
32,542 |
|
$ |
31,957 |
|
|
|
|
||
|
|
|
|
||
Per basic common share: |
|
|
|
||
|
|
|
|
||
Net income from continuing operations applicable to common shares |
$ |
0.21 |
|
$ |
0.14 |
Net income from discontinued operations applicable to common shares |
|
— |
|
|
0.06 |
Net income applicable to common shares |
$ |
0.21 |
|
$ |
0.20 |
|
|
|
|
||
Per diluted common share: |
|
|
|
||
|
|
|
|
||
Net income from continuing operations applicable to common shares |
$ |
0.21 |
|
$ |
0.14 |
Net income from discontinued operations applicable to common shares |
|
— |
|
|
0.06 |
Net income applicable to common shares |
$ |
0.21 |
|
$ |
0.20 |
* Revenues and cost of sales include federal excise taxes of |
TABLE 2
RECONCILIATION OF ADJUSTED EBITDA FROM CONTINUING OPERATIONS (Unaudited) (Dollars in Thousands) |
|||||||||||
Table 2 reflects a reconciliation of GAAP to non-GAAP financial information on a continuing operations basis. Because Douglas Elliman Inc.’s results are reflected within discontinued operations, they are excluded from the financial information provided below. |
|||||||||||
|
LTM |
|
Year Ended |
|
Three Months Ended |
||||||
|
|
|
|
|
|
||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
|
|
|
|
|
|
||||||
Net income attributed to |
$ |
220,048 |
|
$ |
219,463 |
|
$ |
32,542 |
|
$ |
31,957 |
Net income attributed to |
|
(61,902) |
|
|
(72,309) |
|
|
— |
|
|
(10,407) |
Interest expense |
|
109,105 |
|
|
112,728 |
|
|
25,098 |
|
|
28,721 |
Income tax expense |
|
65,815 |
|
|
62,807 |
|
|
12,222 |
|
|
9,214 |
Net loss attributed to non-controlling interest |
|
(190) |
|
|
(190) |
|
|
— |
|
|
— |
Depreciation and amortization |
|
7,610 |
|
|
7,816 |
|
|
1,850 |
|
|
2,056 |
EBITDA |
$ |
340,486 |
|
$ |
330,315 |
|
$ |
71,712 |
|
$ |
61,541 |
Equity in losses (earnings) from investments (a) |
|
144 |
|
|
(2,675) |
|
|
2,242 |
|
|
(577) |
Equity in (earnings) losses from real estate ventures (b) |
|
(6,784) |
|
|
(10,250) |
|
|
1,877 |
|
|
(1,589) |
Loss on extinguishment of debt |
|
— |
|
|
21,362 |
|
|
— |
|
|
21,362 |
Stock-based compensation expense (c) |
|
14,286 |
|
|
14,799 |
|
|
2,147 |
|
|
2,660 |
Litigation settlement and judgment expense (d) |
|
278 |
|
|
211 |
|
|
72 |
|
|
5 |
Impact of MSA settlement (e) |
|
(2,123) |
|
|
(2,722) |
|
|
(2,123) |
|
|
(2,722) |
Transaction expenses (f) |
|
10,468 |
|
|
10,468 |
|
|
— |
|
|
— |
Net gains on sales of assets |
|
(910) |
|
|
(910) |
|
|
— |
|
|
— |
Other, net |
|
(6,836) |
|
|
(10,687) |
|
|
1,145 |
|
|
(2,706) |
Adjusted EBITDA from continuing operations attributed
to |
$ |
349,009 |
|
$ |
349,911 |
|
$ |
77,072 |
|
$ |
77,974 |
|
|
|
|
|
|
|
|
||||
Adjusted EBITDA from Continuing Operations Attributed
to |
|
|
|
|
|
|
|
||||
Tobacco |
$ |
360,830 |
|
$ |
364,399 |
|
$ |
77,076 |
|
$ |
80,645 |
Real Estate |
|
4,063 |
|
|
4,125 |
|
|
1,035 |
|
|
1,097 |
Corporate and Other |
|
(15,884) |
|
|
(18,613) |
|
|
(1,039) |
|
|
(3,768) |
Total |
$ |
349,009 |
|
$ |
349,911 |
|
$ |
77,072 |
|
$ |
77,974 |
a. Represents equity in earnings recognized from investments that the Company accounts for under the equity method.
|
TABLE 3
RECONCILIATION OF ADJUSTED NET INCOME FROM CONTINUING OPERATIONS (Unaudited) (Dollars in Thousands, Except Per Share Amounts) |
|||||
Table 3 reflects a reconciliation of GAAP to non-GAAP financial information on a continuing operations basis. Because Douglas Elliman Inc.’s results are reflected within discontinued operations, they are excluded from the financial information provided below. |
|||||
|
Three Months Ended |
||||
|
|
||||
|
2022 |
|
2021 |
||
|
|
||||
Net income attributed to |
$ |
32,542 |
|
$ |
31,957 |
|
|
|
|
||
Net (income) loss attributed to |
|
— |
|
|
(10,407) |
Loss on extinguishment of debt |
|
— |
|
|
21,362 |
Litigation settlement and judgment expense (a) |
|
72 |
|
|
5 |
Impact of MSA settlement (b) |
|
(2,123) |
|
|
(2,722) |
Impact of net interest expense capitalized to real estate ventures |
|
(3,696) |
|
|
(310) |
Adjustment for derivative associated with guarantee |
|
(1,681) |
|
|
— |
Total adjustments |
|
(7,428) |
|
|
7,928 |
|
|
|
|
||
Tax benefit (expense) related to adjustments |
|
1,483 |
|
|
(4,949) |
|
|
|
|
||
Adjusted Net Income from continuing operations attributed to |
$ |
26,597 |
|
$ |
34,936 |
|
|
|
|
||
Per diluted common share: |
|
|
|
||
|
|
|
|
||
Adjusted Net Income from continuing operations applicable to common shares attributed
to |
$ |
0.17 |
|
$ |
0.22 |
a. Represents accruals for product liability litigation in the Company’s Tobacco segment.
|
TABLE 4
RECONCILIATION OF ADJUSTED OPERATING INCOME (Unaudited) (Dollars in Thousands) |
|||||||||||
Table 4 reflects a reconciliation of GAAP to non-GAAP financial information on a continuing operations basis. Because Douglas Elliman Inc.’s results are reflected within discontinued operations, they are excluded from the financial information provided below. |
|||||||||||
|
LTM |
|
Year Ended |
|
Three Months Ended |
||||||
|
|
|
|
|
|
||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
|
|
|
|
|
|
||||||
Operating income |
$ |
319,590 |
|
$ |
320,439 |
|
$ |
75,126 |
|
$ |
75,975 |
|
|
|
|
|
|
|
|
||||
Litigation settlement and judgment expense (a) |
|
278 |
|
|
211 |
|
|
72 |
|
|
5 |
Transaction expenses (b) |
|
10,468 |
|
|
10,468 |
|
|
— |
|
|
— |
Acceleration of stock compensation expense (c) |
|
4,317 |
|
|
4,317 |
|
|
— |
|
|
— |
Impact of MSA settlement (d) |
|
(2,123) |
|
|
(2,722) |
|
|
(2,123) |
|
|
(2,722) |
Net gains on sales of assets |
|
(910) |
|
|
(910) |
|
|
— |
|
|
— |
Total adjustments |
|
12,030 |
|
|
11,364 |
|
|
(2,051) |
|
|
(2,717) |
|
|
|
|
|
|
|
|
||||
Adjusted Operating Income |
$ |
331,620 |
|
$ |
331,803 |
|
$ |
73,075 |
|
$ |
73,258 |
a. Represents accruals for product liability litigation in the Company’s Tobacco segment.
|
TABLE 5
RECONCILIATION OF TOBACCO ADJUSTED OPERATING INCOME AND TOBACCO ADJUSTED EBITDA (Unaudited) (Dollars in Thousands) |
|||||||||||
|
LTM |
|
Year Ended |
|
Three Months Ended |
||||||
|
|
|
|
|
|
||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
|
|
|
|
|
|
||||||
Tobacco Adjusted Operating Income: |
|
|
|
|
|
|
|
||||
Operating income from Tobacco segment |
$ |
356,357 |
|
$ |
360,317 |
|
$ |
77,639 |
|
$ |
81,599 |
|
|
|
|
|
|
|
|
||||
Litigation settlement and judgment expense (a) |
|
278 |
|
|
211 |
|
|
72 |
|
|
5 |
Impact of MSA settlement (b) |
|
(2,123) |
|
|
(2,722) |
|
|
(2,123) |
|
|
(2,722) |
Total adjustments |
|
(1,845) |
|
|
(2,511) |
|
|
(2,051) |
|
|
(2,717) |
|
|
|
|
|
|
|
|
||||
Tobacco Adjusted Operating Income |
$ |
354,512 |
|
$ |
357,806 |
|
$ |
75,588 |
|
$ |
78,882 |
|
LTM |
|
Year Ended |
|
Three Months Ended |
||||||
|
|
|
|
|
|
||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
|
|
|
|
|
|
|
|
||||
Tobacco Adjusted EBITDA: |
|
|
|
|
|
|
|
||||
Operating income from Tobacco segment |
$ |
356,357 |
|
$ |
360,317 |
|
$ |
77,639 |
|
$ |
81,599 |
|
|
|
|
|
|
|
|
||||
Litigation settlement and judgment expense (a) |
|
278 |
|
|
211 |
|
|
72 |
|
|
5 |
Impact of MSA settlement (b) |
|
(2,123) |
|
|
(2,722) |
|
|
(2,123) |
|
|
(2,722) |
Total adjustments |
|
(1,845) |
|
|
(2,511) |
|
|
(2,051) |
|
|
(2,717) |
|
|
|
|
|
|
|
|
||||
Tobacco Adjusted Operating Income |
|
354,512 |
|
|
357,806 |
|
|
75,588 |
|
|
78,882 |
|
|
|
|
|
|
|
|
||||
Depreciation and amortization |
|
6,242 |
|
|
6,525 |
|
|
1,477 |
|
|
1,760 |
Stock-based compensation expense |
|
76 |
|
|
68 |
|
|
11 |
|
|
3 |
Total adjustments |
|
6,318 |
|
|
6,593 |
|
|
1,488 |
|
|
1,763 |
|
|
|
|
|
|
|
|
||||
Tobacco Adjusted EBITDA |
$ |
360,830 |
|
$ |
364,399 |
|
$ |
77,076 |
|
$ |
80,645 |
a. Represents accruals for product liability litigation in the Company’s Tobacco segment.
|
TABLE 6
RECONCILIATION OF REVENUES (Unaudited) (Dollars in Thousands) |
||||||||||||
|
LTM |
|
Year Ended |
|
Three Months Ended |
|||||||
|
|
|
|
|
|
|||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||
Revenues: |
|
|
|
|
|
|
|
|||||
Tobacco (a) |
$ |
1,243,082 |
|
$ |
1,202,497 |
|
$ |
309,048 |
|
$ |
268,463 |
|
Real estate |
|
18,672 |
|
|
18,203 |
|
|
2,994 |
|
|
2,525 |
|
Total revenues |
$ |
1,261,754 |
|
$ |
1,220,700 |
|
$ |
312,042 |
|
$ |
270,988 |
|
a. Tobacco segment revenues include federal excise taxes of |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005641/en/
212-687-8080
+44 (0)20 3178 8914
J. Bryant Kirkland III,
305-579-8000
Source: